Ultrasound‐Guided Triamcinolone Injections for Hidradenitis Suppurativa Lesions
Journal of Ultrasound in Medicine · 2025-11 · 44 (11) · 1975-1984
DOI: 10.1002/jum.16746 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Ultrasound in Medicine, online erschienen am 18.06.2025. Verfasst von Natalie Hickerson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA. Hauptthemen laut MEDLINE: Triamcinolone, Ultrasonography, Interventional, Hidradenitis Suppurativa, Anti-Inflammatory Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
To evaluate the role of ultrasound (US) guidance in intralesional triamcinolone (TAC) injections for hidradenitis suppurativa (HS) lesions and assess its impact on injection technique, clinical response rates, and patient‐reported outcomes.
Methods
We conducted a systematic review of PubMed, Embase, and Cochrane databases from inception through October 2024. Studies that reported outcomes of US‐guided TAC injections in patients with HS lesions (nodules, abscesses, or tunnels) were included. Data extraction included study design, lesion type, TAC concentration used, injection technique, clinical outcomes, and adverse events. Meta‐analysis was performed to evaluate pooled clinical response rates, complete healing rates, and pain reduction. The protocol was registered on PROSPERO (CRD42024596593).
Results
Six studies encompassing 313 patients and 527 lesions were included. The pooled clinical response rate was 80.5% across all lesion types, with highest rates observed for abscesses (96.4%) and nodules (93.4%). Complete clinical healing was achieved in 69.8% of lesions. Meta‐analysis of pain outcomes from 3 studies demonstrated a significant reduction in mean pain scores (standardized mean difference: −0.57; 95% CI: [−0.76, −0.37]; P = .0013). Adverse events were rare (5.4%) and no severe complications were reported.
Conclusions
US‐guided TAC injections are a safe and potentially effective approach to treating HS lesions, particularly for complex or deep lesions. While preliminary data are promising, further randomized controlled studies are needed to directly compare outcomes with non‐US‐guided injections and to establish standardized protocols for injection technique.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
ORCID-Profile: Natalie Hickerson
Zitieren
APA
Hickerson, N., Lam, T. K., & Lev-Tov, H. (2025). Ultrasound‐Guided Triamcinolone Injections for Hidradenitis Suppurativa Lesions. Journal of Ultrasound in Medicine, 44(11), 1975-1984. https://doi.org/10.1002/jum.16746
Vancouver
Hickerson N, Lam TK, Lev-Tov H. Ultrasound‐Guided Triamcinolone Injections for Hidradenitis Suppurativa Lesions. Journal of Ultrasound in Medicine. 2025;44(11):1975-1984. doi:10.1002/jum.16746
BibTeX
@article{Hickerson2025,
author = {Hickerson, Natalie and Lam, Thao Kimmy and Lev-Tov, Hadar},
title = {Ultrasound‐Guided Triamcinolone Injections for Hidradenitis Suppurativa Lesions},
journal = {Journal of Ultrasound in Medicine},
year = {2025},
volume = {44},
number = {11},
pages = {1975--1984},
doi = {10.1002/jum.16746}
}
EUVIMED